𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transthyretin as a potential CSF biomarker for Alzheimer’s disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors

✍ Scribed by K. Schultz; K. Nilsson; J. E. Nielsen; S. G. Lindquist; L. E. Hjermind; B. B. Andersen; A. Wallin; C. Nilsson; Å. Petersén


Book ID
111066169
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
121 KB
Volume
17
Category
Article
ISSN
1351-5101

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Economic evaluation of cholinesterase in
✍ Anders Gustavsson; Rohan Van Der Putt; Linus Jönsson; Rupert McShane 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## Objective To assess the cost effectiveness of cholinesterase inhibitor (ChEI) treatment in patients with Alzheimer's disease (AD) and Dementia with Lewy bodies (DLB). ## Method We used 4‐month open label follow‐up data from routine memory clinic patients. There were 852 patients w